Italian guidelines on thrombolysis indications in ischaemic stroke have been revised after IST 3 trial and Cochrane Review: PROS

Internal and Emergency Medicine

Volumn 8, Issue 8, 2013, Pages 653-654

  Ricci, Stefano ^a   Cenciarelli, Silvia ^a   Mazzoli, Tatiana ^a  

^a Centro di Coordinamento IST 3 per l' Italia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ISCHEMIA; COMPLICATION; FIBRINOLYTIC THERAPY; HUMAN; ITALY; LITERATURE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROKE;

BRAIN ISCHEMIA; HUMANS; ITALY; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC; STROKE; THROMBOLYTIC THERAPY;

EID: 84888308090     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-013-0987-x     Document Type: Editorial

References (12)

1. The IST-3 collaborative group (2012) The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379: 2352-2363.
2. Wardlaw J, Murray V, Berge E, Del Zoppo G, Sandercock P, Lindley R, Cohen G (2012) Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 379: 2364-2372.
3. Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P, IST-3 collaborative group (2008) The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials 9: 37.
4. Shinar D, Gross CR, Bronstein KS, Licata-Gehr EE, Eden DT, Cabrera AR, Fishman IG, Roth AA, Barwick JA, Kunitz SC (1987) Reliability of the activities of daily living scale and its use in telephone interview. Arch Phys Med Rehabil 68: 723-728.
5. Candelise L, Pinardi G, Aritzu E, Musicco M (1994) Telephone interview for stroke outcome assessment. Cerebrovasc Dis 4: 341-343.
6. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, Von Kummer R, Wahlgren N, Toni D, ECASS Investigators (2008) Thrombolysis with alteplase 3 to 4. 5 hours after acute ischemic stroke. N Engl J Med 359: 1317-1329.
7. Saver J (2007) Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials. Stroke 38: 3055-3062.
8. Bath PMW, Lees KR, Schellinger PD, Altman H, Bland M, Hogg C, Howard G, Saver JL (2012) Statistical analysis of the primary outcome in acute stroke trials. Stroke 43: 1171-1178.
9. IST 3 Collaborative Group (2012) Statistical analysis plan for the third International Stroke Trial (IST-3); part of a 'thread' of reports of the trial. Int J Stroke 7: 186-187.
10. The IST-3 collaborative group. Effects of thrombolysis with recombinant tissue plasminogen activator for acute ischaemic stroke on long term outcomes in the third international stroke trial (IST-3): a randomised controlled trial. Lancet Neurol, Early Online Publication, 21 June 2013.
11. Del Medico M, Bonura A (2013) Can we extend thrombolysis indications for acute ischaemic stroke? The IST-3 study. Intern Emerg Med 8: 261-262.
12. Leys D, Cordonnier C (2012) rt-PA for ischaemic stroke: what will the next question be? Lancet 379: 2320-2321.